12.07.2015 Views

Corporate Magazine 2012 - Boehringer Ingelheim

Corporate Magazine 2012 - Boehringer Ingelheim

Corporate Magazine 2012 - Boehringer Ingelheim

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

our businessesperspectives for better healthJENTADUETO®jentadueto® is a twice-daily combinationof two diabetes medicines, linagliptin andmetformin. It can be used along with dietand exercise to help control blood sugar inadults with type 2 diabetes when treatmentwith both compounds is appropriate.Our Diabetes Health Lounge:The website combines educational videosand games, research tools and informationon type 2 diabetes.For more information see:www.diabeteshealthlounge.comeral questions. How many patients withdiabetes have some degree of renal impairment?What is their prognosis? Howdoes it impact their quality of life? Andlastly, what are the consequences for thedoctor, in terms of treatment approaches?Diabate © websiteSponsored by an unconditional educationalgrant from <strong>Boehringer</strong> <strong>Ingelheim</strong>,Diabate © is a resource for all medicallyqualified practitioners with an interestin the treatment of diabetes. It bringstogether experts in diabetes, diabeticrenal impairment and cardiovasculardisease in an ongoing programme toreview, discuss and understand the latestscientific developments relevant tothe overall topic of diabetes and renaldisease.Web, smartphone and type 2 diabetesWe have partnered with the digitalhealth management company Healthrageous,Inc. to study a web and smartphone-basedlifestyle behaviour modificationprogramme. The goal is to usetechnology to produce an easier andmore effective way for patients to selfmanagetheir diabetes and improvetheir health status. Study participants,who must have been diagnosed withtype 2 diabetes for at least six months,experience a digital technology interventioncombining digital coaching anda wireless glucose meter transmittingdata to clinical monitors.My Well Planner In <strong>2012</strong>, <strong>Boehringer</strong> <strong>Ingelheim</strong> and EliLilly and Company introduced the MyWell Planner lifestyle improvementprogramme in the USA. The free, comprehensiveresource offers customisededucational content to help adults withtype 2 diabetes make simple lifestylechanges to improve their health. Sampletopics include general informationabout type 2 diabetes, better eating habits,building physical activity into dailylife, taking medication and communicationstrategies.The programme also creates progressreports, which patients can print outDIABATE © WEBSITEIt brings together diabetes expertsin an ongoing programme toreview, discuss and understandthe latest scientific developmentsrelevant to the overall topic ofdiabetes and renal disease.For more information see:www.diabate.tvLiving better with diabetes77

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!